Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06558799
Title LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) (LUNAR-4)
Acronym LUNAR-4
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NovoCure GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUT


No variant requirements are available.